• Explore /
  • Poster
  • / A multicenter phase II trial of the combination cisplatin/ docetaxel/durvalumab/tremelimumab as single-cycle induction treatment in locally advanced HNSCC (CheckRad-CD8 trial).

A multicenter phase II trial of the combination cisplatin/ docetaxel/durvalumab/tremelimumab as single-cycle induction treatment in locally advanced HNSCC (CheckRad-CD8 trial).

Abstract Poster

Authors

Markus Hecht

Markus Hecht

Department of Radiation Oncology, Universitatsklinikum Erlangen, Friedrich-Alexander-Universitat Erlangen-Nürnberg, Erlangen, Germany

Markus Hecht , Antoniu-Oreste Gostian , Markus Eckstein , Sandra Rutzner , Jens von der Grün , Thomas Illmer , Matthias G. Hautmann , Thomas Brunner , Simon Laban , Gunther Klautke , Balint Tamaskovics , Axel Hinke , Benjamin Frey , Sabine Semrau , Arndt Hartmann , Claus Roedel , Wilfried Budach , Udo S Gaipl , Heinrich Iro , Rainer Fietkau

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Discussion Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Local-Regional Disease

Clinical Trial Registration Number

NCT03426657

Citation

J Clin Oncol 38: 2020 (suppl; abstr 6519)

DOI

10.1200/JCO.2020.38.15_suppl.6519

Abstract #

6519

Poster Bd #

180

Abstract Disclosures

Similar Posters

First Author: Markus Hecht

First Author: Hirva Mansurali Mamdani

First Author: Jing Chen

First Author: Sacha Rothschild